NO20021566L - Bicykliske imidazo-5-yl-aminderivater - Google Patents

Bicykliske imidazo-5-yl-aminderivater

Info

Publication number
NO20021566L
NO20021566L NO20021566A NO20021566A NO20021566L NO 20021566 L NO20021566 L NO 20021566L NO 20021566 A NO20021566 A NO 20021566A NO 20021566 A NO20021566 A NO 20021566A NO 20021566 L NO20021566 L NO 20021566L
Authority
NO
Norway
Prior art keywords
amine derivatives
bicyclic imidazo
imidazo
bicyclic
amine
Prior art date
Application number
NO20021566A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021566D0 (no
Inventor
Matthias Gerlach
Corinna Maul
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999148436 external-priority patent/DE19948436B4/de
Priority claimed from DE19948434A external-priority patent/DE19948434A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20021566D0 publication Critical patent/NO20021566D0/no
Publication of NO20021566L publication Critical patent/NO20021566L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20021566A 1999-10-08 2002-04-03 Bicykliske imidazo-5-yl-aminderivater NO20021566L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999148436 DE19948436B4 (de) 1999-10-08 1999-10-08 Bicyclische Imidazo-5-aminderivate
DE19948434A DE19948434A1 (de) 1999-10-08 1999-10-08 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
PCT/EP2000/009097 WO2001027118A2 (de) 1999-10-08 2000-09-18 Bicyclische imidazo-5-yl-aminderivate

Publications (2)

Publication Number Publication Date
NO20021566D0 NO20021566D0 (no) 2002-04-03
NO20021566L true NO20021566L (no) 2002-05-27

Family

ID=26055216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021566A NO20021566L (no) 1999-10-08 2002-04-03 Bicykliske imidazo-5-yl-aminderivater

Country Status (29)

Country Link
US (2) US6657064B2 (he)
EP (1) EP1218383B1 (he)
JP (1) JP2003511456A (he)
KR (1) KR20020068515A (he)
CN (1) CN1211385C (he)
AR (1) AR030030A1 (he)
AT (1) ATE413403T1 (he)
AU (1) AU781227B2 (he)
BR (1) BR0014817A (he)
CA (1) CA2388476C (he)
CO (1) CO5200851A1 (he)
CY (1) CY1110416T1 (he)
CZ (1) CZ20021242A3 (he)
DE (1) DE50015443D1 (he)
DK (1) DK1218383T3 (he)
ES (1) ES2316388T3 (he)
HK (1) HK1047746A1 (he)
HU (1) HUP0203140A3 (he)
IL (2) IL149010A0 (he)
MX (1) MXPA02002837A (he)
NO (1) NO20021566L (he)
PE (1) PE20010638A1 (he)
PL (1) PL355019A1 (he)
PT (1) PT1218383E (he)
RU (1) RU2002110112A (he)
SI (1) SI1218383T1 (he)
SK (1) SK4642002A3 (he)
UY (1) UY26370A1 (he)
WO (1) WO2001027118A2 (he)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0014817A (pt) * 1999-10-08 2002-06-18 Gruenenthal Gmbh Imidazo-5-il-aminas bicìclicas, medicamentos que as contém, seu emprego para a preparação de medicamentos e procedimento para sua preparação
US6380228B1 (en) 2000-04-10 2002-04-30 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
DE10043845A1 (de) * 2000-09-06 2002-03-14 Gruenenthal Gmbh Verfahren zur Messung der Aktivität der NO-Synthase
KR100647583B1 (ko) * 2003-10-07 2006-11-17 삼성에스디아이 주식회사 이미다졸 고리 함유 화합물 및 이를 이용한 유기 전계발광 소자
WO2006065788A2 (en) * 2004-12-13 2006-06-22 Glaxo Group Limited Novel muscarinic acetylcholine receptor antagonists
US7923041B2 (en) * 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
DE102006011574A1 (de) * 2006-03-10 2007-10-31 Grünenthal GmbH Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
WO2007138072A2 (en) * 2006-05-31 2007-12-06 Galapagos N.V. Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
WO2008016648A2 (en) * 2006-08-01 2008-02-07 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
KR101410453B1 (ko) * 2006-08-02 2014-06-27 싸이토키네틱스, 인코포레이티드 소정의 화학 물질, 조성물 및 방법
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP2139478A4 (en) * 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
EP2217069A4 (en) * 2007-11-09 2012-03-14 Salk Inst For Biological Studi INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
PT2266990E (pt) * 2008-04-15 2012-12-27 Eisai R&D Man Co Ltd Composto de 3-fenilpirazolo[5,1-b]tiazole
US8377945B2 (en) * 2009-06-15 2013-02-19 Rigel Pharmaceuticals Inc. Small molecule inhibitors of spleen tyrosine kinase (SYK)
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
EA028060B1 (ru) 2011-07-13 2017-10-31 Сайтокинетикс, Инк. Комбинированная терапия бокового амиотрофического склероза
EP2855489B1 (en) 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
KR20150003767A (ko) 2012-04-26 2015-01-09 브리스톨-마이어스 스큅 컴퍼니 혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 유도체
BR112014026643B1 (pt) 2012-04-26 2023-03-07 Universite De Montreal Derivados de imidazotiadiazol e imidazopirazina como inibidores de receptor 4 ativado por protease (par4) para o tratamento de agregação de plaqueta, seus usos e composição farmacêutica
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
KR102599388B1 (ko) * 2017-09-01 2023-11-09 현대자동차주식회사 피드백 제어방법 및 시스템

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274551B (he) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
BR0014817A (pt) * 1999-10-08 2002-06-18 Gruenenthal Gmbh Imidazo-5-il-aminas bicìclicas, medicamentos que as contém, seu emprego para a preparação de medicamentos e procedimento para sua preparação

Also Published As

Publication number Publication date
PT1218383E (pt) 2009-01-29
CN1211385C (zh) 2005-07-20
CZ20021242A3 (cs) 2002-08-14
DE50015443D1 (de) 2008-12-18
EP1218383B1 (de) 2008-11-05
KR20020068515A (ko) 2002-08-27
ATE413403T1 (de) 2008-11-15
EP1218383A2 (de) 2002-07-03
DK1218383T3 (da) 2009-01-19
NO20021566D0 (no) 2002-04-03
WO2001027118A2 (de) 2001-04-19
US6936631B2 (en) 2005-08-30
CA2388476A1 (en) 2001-04-19
CO5200851A1 (es) 2002-09-27
AR030030A1 (es) 2003-08-13
SK4642002A3 (en) 2002-09-10
JP2003511456A (ja) 2003-03-25
CN1402726A (zh) 2003-03-12
UY26370A1 (es) 2000-12-29
IL149010A0 (en) 2002-11-10
AU781227B2 (en) 2005-05-12
CY1110416T1 (el) 2015-04-29
MXPA02002837A (es) 2002-08-30
HUP0203140A3 (en) 2004-06-28
WO2001027118A3 (de) 2001-09-20
HK1047746A1 (en) 2003-03-07
US6657064B2 (en) 2003-12-02
HUP0203140A2 (hu) 2003-01-28
RU2002110112A (ru) 2003-12-20
CA2388476C (en) 2008-08-05
ES2316388T3 (es) 2009-04-16
IL149010A (he) 2007-06-17
US20020183320A1 (en) 2002-12-05
AU7777200A (en) 2001-04-23
SI1218383T1 (sl) 2009-04-30
US20040023927A1 (en) 2004-02-05
PL355019A1 (en) 2004-03-22
PE20010638A1 (es) 2001-07-07
BR0014817A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
DE50005155D1 (de) Bicyclische imidazo-3-yl-aminderivate
FR15C0096I2 (fr) Derives carbamoyloxyalkyl-azolium n-substitues
ATE413403T1 (de) Bicyclische imidazo-5-yl-aminderivate
IS5381A (is) 4-fenyl-pyridin afleiður
NO20021077D0 (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
DE50010060D1 (de) Thiazolylamid-derivate
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de) Resorcinderivate
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
DE60001736T2 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
NO20021310D0 (no) Aminderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application